Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    11554952 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Withdrawn Prochlorperazine Versus Prochlorperazine & Ketorolac in Treatment of Pediatric Migraine in the Emergency Department
Condition: Migraine
Interventions: Drug: Ketorolac;   Drug: Placebo

Indicates status has not been verified in more than two years